ADPT vs SNY
Adaptive Biotechnologies Corp (ADPT) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
SNY (SNY) common stock.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
SNY does not have a complete income-statement cache yet.
ADPT currently screens at market cap $2.69B. SNY currently screens at market cap $0.
Not investment advice. Open the ADPT and SNY stock pages for the full models.
Not investment advice.